Karo Pharma AB buy Morgan Stanley
Start price
24.07.23
/
50%
€5.44
Target price
24.07.24
€30.66
Performance (%)
-
End price
25.07.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Karo Pharma AB | - | - | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
Comments by Morgan_Stanley for this prediction
In the thread Karo Pharma AB diskutieren
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Morgan Stanley from $37.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
In the thread Trading Karo Pharma AB
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten